19-11447525-AGAGGAGGAGGAGGAGGAG-AGAGGAGGAGGAGGAGGAGGAGGAG

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP3BS1_SupportingBS2

The NM_001289104.2(PRKCSH):​c.963_968dupGGAGGA​(p.Glu322_Glu323dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. E323E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00074 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00023 ( 0 hom. )

Consequence

PRKCSH
NM_001289104.2 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.52

Publications

11 publications found
Variant links:
Genes affected
PRKCSH (HGNC:9411): (PRKCSH beta subunit of glucosidase II) This gene encodes the beta-subunit of glucosidase II, an N-linked glycan-processing enzyme in the endoplasmic reticulum. The encoded protein is an acidic phosphoprotein known to be a substrate for protein kinase C. Mutations in this gene have been associated with the autosomal dominant polycystic liver disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
PRKCSH Gene-Disease associations (from GenCC):
  • polycystic liver disease 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001289104.2
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000742 (111/149626) while in subpopulation AFR AF = 0.00214 (87/40622). AF 95% confidence interval is 0.00178. There are 0 homozygotes in GnomAd4. There are 57 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 111 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRKCSHNM_001289104.2 linkc.963_968dupGGAGGA p.Glu322_Glu323dup disruptive_inframe_insertion Exon 11 of 18 ENST00000677123.1 NP_001276033.1 K7ELL7B4DJQ5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRKCSHENST00000677123.1 linkc.963_968dupGGAGGA p.Glu322_Glu323dup disruptive_inframe_insertion Exon 11 of 18 NM_001289104.2 ENSP00000503163.1 K7ELL7

Frequencies

GnomAD3 genomes
AF:
0.000742
AC:
111
AN:
149518
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00215
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000398
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000395
Gnomad SAS
AF:
0.00107
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000163
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000308
AC:
54
AN:
175324
AF XY:
0.000220
show subpopulations
Gnomad AFR exome
AF:
0.00147
Gnomad AMR exome
AF:
0.000335
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000496
Gnomad FIN exome
AF:
0.000252
Gnomad NFE exome
AF:
0.000163
Gnomad OTH exome
AF:
0.000230
GnomAD4 exome
AF:
0.000229
AC:
328
AN:
1434296
Hom.:
0
Cov.:
0
AF XY:
0.000222
AC XY:
158
AN XY:
712774
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00195
AC:
64
AN:
32884
American (AMR)
AF:
0.000285
AC:
12
AN:
42036
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25668
East Asian (EAS)
AF:
0.000102
AC:
4
AN:
39096
South Asian (SAS)
AF:
0.000321
AC:
27
AN:
84050
European-Finnish (FIN)
AF:
0.000174
AC:
9
AN:
51680
Middle Eastern (MID)
AF:
0.000361
AC:
2
AN:
5546
European-Non Finnish (NFE)
AF:
0.000178
AC:
195
AN:
1093996
Other (OTH)
AF:
0.000253
AC:
15
AN:
59340
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.397
Heterozygous variant carriers
0
18
36
54
72
90
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000742
AC:
111
AN:
149626
Hom.:
0
Cov.:
0
AF XY:
0.000782
AC XY:
57
AN XY:
72902
show subpopulations
African (AFR)
AF:
0.00214
AC:
87
AN:
40622
American (AMR)
AF:
0.000398
AC:
6
AN:
15092
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3436
East Asian (EAS)
AF:
0.000396
AC:
2
AN:
5054
South Asian (SAS)
AF:
0.00107
AC:
5
AN:
4678
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10162
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000163
AC:
11
AN:
67348
Other (OTH)
AF:
0.00
AC:
0
AN:
2052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000108
Hom.:
370

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Oct 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant, c.963_968dup, results in the insertion of 2 amino acid(s) of the PRKCSH protein (p.Glu324_Glu325dup), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with PRKCSH-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.5
Mutation Taster
=75/25
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3217229; hg19: chr19-11558340; API